{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:25:57Z","timestamp":1769588757035,"version":"3.49.0"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T00:00:00Z","timestamp":1234828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background:<\/jats:title><jats:p>Percutaneous closure of patent foramen ovale (PFO) is routinely performed with nonbiological devices, characterized by a persistent low\u2010grade inflammatory response. We report our experience about PFO closure with a bioabsorbable device, BioSTAR\u00ae (NMT Inc, USA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>From September 2007 to September 2008, 14 patients with migraine (eight with aura) and cerebral magnetic resonance positive for silent ischemia and nine patients with prior cardiovascular accident (CVA) underwent closure of PFO using BioSTAR\u00ae. One patient had heterozygosis for sickle\u2010cell\u2010anaemia. Nickel allergy was present in eight patients. Echocardiogram was performed at 24 hr, one and 6 months. At 6 and 12 months a contrast\u2010transcranial\u2010doppler (c\u2010TCD) and a trans\u2010oesophageal echocardiogram (TOE) were scheduled, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>BioSTAR\u00ae was successfully implanted in 22 patients (96%). The mean procedural time and the mean fluoroscopy time were 22 \u00b1 6 and 4 \u00b1 2 minutes, respectively. The mean in\u2010hospital stay was 3 \u00b1 0.5 days. After a mean follow\u2010up of 7.8 \u00b1 3.5 months there was an hemorrhagic stroke related to double antiaggregation. No other CVA or allergic reactions were registered. There were two cases of atrial arrhythmia. Fifteen patients had not residual shunts at c\u2010TCD, while in four patients we observed a trivial microbubbles passage. The TOE, achieved in nine patients without contrast, showed the device well positioned, with a low profile and without thrombus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>In our experience PFO closure with BioSTAR\u00ae is safe and efficacious in preventing recurrent CVA. Its use could be advantageous in patients with nickel allergy and haematological disorders. The potential benefits of this device need to be certified in a larger cohort of patients with a longer follow\u2010up. \u00a9 2009 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.22033","type":"journal-article","created":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T20:53:27Z","timestamp":1234904007000},"page":"607-614","source":"Crossref","is-referenced-by-count":23,"title":["Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device"],"prefix":"10.1002","volume":"74","author":[{"given":"Gian Paolo","family":"Ussia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Cammalleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Mul\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Scarabelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Barbanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Scardaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Mangiafico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Imm\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Tamburino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/hs0102.100883"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-6-461"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Patent foramen ovale and atrial septal aneurysm study group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas JL","year":"2001","journal-title":"N Engl J Med"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.8.1622"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.81.3.257"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2005.00072.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01427-9"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.6.960"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050804"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1522-726X(200102)52:2<194::AID-CCD1046>3.0.CO;2-4"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000027819.19722.EE"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000199147.30016.74"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2005.00043.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.02.057"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.7.1459"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.664672"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(85)80228-X"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000016119"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100720100064"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8183.2003.08027.x"},{"key":"e_1_2_6_22_2","first-page":"22","article-title":"Percutaneous closure of patent foramen ovale: Head\u2010to\u2010head comparison of two different devices","volume":"1","author":"Meier JM","year":"2005","journal-title":"EuroIntervention"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20220"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.10.030"},{"key":"e_1_2_6_25_2","first-page":"E247","article-title":"Late presentation of CardioSEAL PFO closure device fracture and thrombus formation three years after device implantation","volume":"20","author":"Narayan V","year":"2008","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20211"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(03)00901-9"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20497"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.12.017"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2003.125"},{"key":"e_1_2_6_31_2","first-page":"681","article-title":"Nickel allergy and the amplatzer septal occluder","volume":"16","author":"Singh HR","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_6_32_2","first-page":"365","article-title":"Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale","volume":"18","author":"Alaeddini J","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.2143\/AC.60.5.2004973"},{"key":"e_1_2_6_34_2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood.V49.6.967.967","article-title":"Red cells in sickle cell crisis: Observations on the pathophysiology of crisis","volume":"49","author":"Rieber EE","year":"1977","journal-title":"Blood"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.820080322"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.7"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8183.2003.08005.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.05.044"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.22033","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.22033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T14:11:37Z","timestamp":1697465497000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.22033"}},"subtitle":["Single\u2010Centre Experience"],"short-title":[],"issued":{"date-parts":[[2009,4,9]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1002\/ccd.22033"],"URL":"https:\/\/doi.org\/10.1002\/ccd.22033","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,9]]}}}